Cargando…
Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey
Population-based serological testing is important to understand the epidemiology and estimate the true cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inform public health interventions. This study reports findings of a national household population SARS-CoV-2...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519586/ https://www.ncbi.nlm.nih.gov/pubmed/37747851 http://dx.doi.org/10.1371/journal.pgph.0002358 |
_version_ | 1785109732252450816 |
---|---|
author | Moyo, Sizulu Simbayi, Leickness C. Zuma, Khangelani Zungu, Nompumelelo Marinda, Edmore Jooste, Sean Ramlagan, Shandir Fortuin, Mirriam Singh, Beverley Mabaso, Musawenkosi Reddy, Tarylee Parker, Whadi-ah Naidoo, Inbarani Manda, Samuel Goga, Ameena Ngandu, Nobubelo Cawood, Cherie Moore, Penny L. Puren, Adrian |
author_facet | Moyo, Sizulu Simbayi, Leickness C. Zuma, Khangelani Zungu, Nompumelelo Marinda, Edmore Jooste, Sean Ramlagan, Shandir Fortuin, Mirriam Singh, Beverley Mabaso, Musawenkosi Reddy, Tarylee Parker, Whadi-ah Naidoo, Inbarani Manda, Samuel Goga, Ameena Ngandu, Nobubelo Cawood, Cherie Moore, Penny L. Puren, Adrian |
author_sort | Moyo, Sizulu |
collection | PubMed |
description | Population-based serological testing is important to understand the epidemiology and estimate the true cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inform public health interventions. This study reports findings of a national household population SARS-CoV-2 serosurvey in people 12 years and older in South Africa. This cross-sectional multi-stage random stratified cluster survey undertaken from November 2020 to June 2021 collected sociodemographic data, medical history, behavioural data, and blood samples from consenting participants. The samples were tested for SARS-CoV-2 antibodies using the Roche ElecsysAnti-SARS-CoV-2 chemiluminescence immunoassay (CLIA) Total Antibody Test. The survey data were weighted by age, race, sex, and province with final individual weights benchmarked against the 2020 mid-year population estimates and accounted for clustering. Descriptive statistics summarize the characteristics of participants and seroprevalence. Logistic regression analyses were used to identify factors associated with seropositivity. From 13290 survey participants (median age 33 years, interquartile range (IQR) 23–46 years), SARS-CoV-2 seroprevalence was 37.8% [95% Confidence Interval (CI) 35.4–40.4] and varied substantially across the country’s nine provinces, and by sex, age and locality type. In the final adjusted model, the odds of seropositivity were higher in women than in men [aOR = 1.3 (95% CI: 1.0–1.6), p = 0.027], and those living with HIV (self-report) [aOR = 1.6 (95% CI: 1.0–2.4), p = 0.031]. The odds were lower among those 50 years and older compared to adolescents 12–19 years old [aOR = 0.6 (95% CI: 0.5–0.8), p<0.001] and in those who did not attend events or gatherings [aOR = 0.7 (95% CI: 0.6–1.0), p = 0.020]. The findings help us understand the epidemiology of SARS-CoV-2 within different regions in a low-middle-income country. The survey highlights the higher risk of infection in women in South Africa likely driven by their home and workplace roles and also highlighted a need to actively target and include younger people in the COVID-19 response. |
format | Online Article Text |
id | pubmed-10519586 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-105195862023-09-26 Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey Moyo, Sizulu Simbayi, Leickness C. Zuma, Khangelani Zungu, Nompumelelo Marinda, Edmore Jooste, Sean Ramlagan, Shandir Fortuin, Mirriam Singh, Beverley Mabaso, Musawenkosi Reddy, Tarylee Parker, Whadi-ah Naidoo, Inbarani Manda, Samuel Goga, Ameena Ngandu, Nobubelo Cawood, Cherie Moore, Penny L. Puren, Adrian PLOS Glob Public Health Research Article Population-based serological testing is important to understand the epidemiology and estimate the true cumulative incidence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to inform public health interventions. This study reports findings of a national household population SARS-CoV-2 serosurvey in people 12 years and older in South Africa. This cross-sectional multi-stage random stratified cluster survey undertaken from November 2020 to June 2021 collected sociodemographic data, medical history, behavioural data, and blood samples from consenting participants. The samples were tested for SARS-CoV-2 antibodies using the Roche ElecsysAnti-SARS-CoV-2 chemiluminescence immunoassay (CLIA) Total Antibody Test. The survey data were weighted by age, race, sex, and province with final individual weights benchmarked against the 2020 mid-year population estimates and accounted for clustering. Descriptive statistics summarize the characteristics of participants and seroprevalence. Logistic regression analyses were used to identify factors associated with seropositivity. From 13290 survey participants (median age 33 years, interquartile range (IQR) 23–46 years), SARS-CoV-2 seroprevalence was 37.8% [95% Confidence Interval (CI) 35.4–40.4] and varied substantially across the country’s nine provinces, and by sex, age and locality type. In the final adjusted model, the odds of seropositivity were higher in women than in men [aOR = 1.3 (95% CI: 1.0–1.6), p = 0.027], and those living with HIV (self-report) [aOR = 1.6 (95% CI: 1.0–2.4), p = 0.031]. The odds were lower among those 50 years and older compared to adolescents 12–19 years old [aOR = 0.6 (95% CI: 0.5–0.8), p<0.001] and in those who did not attend events or gatherings [aOR = 0.7 (95% CI: 0.6–1.0), p = 0.020]. The findings help us understand the epidemiology of SARS-CoV-2 within different regions in a low-middle-income country. The survey highlights the higher risk of infection in women in South Africa likely driven by their home and workplace roles and also highlighted a need to actively target and include younger people in the COVID-19 response. Public Library of Science 2023-09-25 /pmc/articles/PMC10519586/ /pubmed/37747851 http://dx.doi.org/10.1371/journal.pgph.0002358 Text en © 2023 Moyo et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Moyo, Sizulu Simbayi, Leickness C. Zuma, Khangelani Zungu, Nompumelelo Marinda, Edmore Jooste, Sean Ramlagan, Shandir Fortuin, Mirriam Singh, Beverley Mabaso, Musawenkosi Reddy, Tarylee Parker, Whadi-ah Naidoo, Inbarani Manda, Samuel Goga, Ameena Ngandu, Nobubelo Cawood, Cherie Moore, Penny L. Puren, Adrian Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey |
title | Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey |
title_full | Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey |
title_fullStr | Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey |
title_full_unstemmed | Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey |
title_short | Seroprevalence survey of anti-SARS-CoV-2 antibody and associated factors in South Africa: Findings of the 2020–2021 population-based household survey |
title_sort | seroprevalence survey of anti-sars-cov-2 antibody and associated factors in south africa: findings of the 2020–2021 population-based household survey |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10519586/ https://www.ncbi.nlm.nih.gov/pubmed/37747851 http://dx.doi.org/10.1371/journal.pgph.0002358 |
work_keys_str_mv | AT moyosizulu seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT simbayileicknessc seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT zumakhangelani seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT zungunompumelelo seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT marindaedmore seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT joostesean seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT ramlaganshandir seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT fortuinmirriam seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT singhbeverley seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT mabasomusawenkosi seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT reddytarylee seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT parkerwhadiah seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT naidooinbarani seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT mandasamuel seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT gogaameena seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT ngandunobubelo seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT cawoodcherie seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT moorepennyl seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey AT purenadrian seroprevalencesurveyofantisarscov2antibodyandassociatedfactorsinsouthafricafindingsofthe20202021populationbasedhouseholdsurvey |